Rajendran Vairagoundar

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 187(Granted Patents)

Location History:

San Marcos, CA (US) (2011)
Portage, MI (US) (2014)
Kalamazoo, MI (US) (2013 - 2023)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

2 out of 8

Chembridge Corporation

Years Active: 2011-2025

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12295936 - Immunomodulating urea azalides (2025-05-13),

2. 11786575 - Endoparasitic depsipeptides (2023-10-17),

3. 11771738 - Endoparasitic depsipeptides (2023-10-03),

4. 11771677 - Immunomodulating urea azalides (2023-10-03),

5. 11331369 - Endoparasitic depsipeptides (2022-05-17),

6. 9422236 - Phenicol antibacterial agents (2016-08-23),

7. 9206126 - Phenicol antibacterial agents (2015-12-08),

8. 9145355 - Phenicol antibacterials (2015-09-29),

9. 8815906 - Tyrosine kinase inhibitors (2014-08-26),

10. 8802700 - Modulators of ATP-Binding Cassette transporters (2014-08-12),

11. 8722656 - Cephalosporins useful as antibacterial agents (2014-05-13),

12. 8614327 - Modulators of ATP-binding cassette transporters (2013-12-24),

13. 8063225 - Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders (2011-11-22),

Title: The Innovator: Rajendran Vairagoundar

Introduction:

Rajendran Vairagoundar is a prolific inventor based in Kalamazoo, MI, with a remarkable track record of 10 patented inventions to his name. His groundbreaking work in the field of endoparasitic depsipeptides has garnered attention and accolades in the scientific community.

Latest Patents:

One of Rajendran Vairagoundar's latest patents involves cyclic depsipeptides of Formula (1), and veterinary acceptable salts thereof, targeted towards treating endoparasitic infections in animals. These compounds hold promising potential in revolutionizing the treatment of such conditions, showcasing Vairagoundar's innovative prowess.

Career Highlights:

Having worked with esteemed companies such as Zoetis Services LLC and Vertex Pharmaceuticals, Inc., Rajendran Vairagoundar has left a lasting impact on the biopharmaceutical industry. His dedication to research and development has led to the successful patenting of novel compounds that have the potential to address significant unmet medical needs.

Collaborations:

Throughout his career, Rajendran Vairagoundar has collaborated with accomplished individuals in the field, including Richard Andrew Ewin and Graham M Kyne. These collaborations have not only enriched his own work but have also contributed to the advancement of scientific knowledge in the realm of biopharmaceuticals.

Conclusion:

In conclusion, Rajendran Vairagoundar stands as a shining example of an inventive mind dedicated to pushing the boundaries of scientific innovation. His contributions to the field of endoparasitic depsipeptides underscore his commitment to improving animal health and welfare through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.